Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 2,340 | 2,349 |
| Other current assets | 0 | 0 | 0 | 800 | 797 |
| TOTAL | $0 | $0 | $0 | $3,140 | $3,147 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 9,820 | 8,010 |
| Other Non-Current Assets | 0 | 0 | 0 | 440 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $10,260 | $8,010 |
| Total Assets | $0 | $0 | $0 | $11,600 | $11,604 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 720 | N/A |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 3,100 | 0 |
| Accrued Expenses | 0 | 0 | 0 | 2,560 | N/A |
| Other current liabilities | 0 | 0 | 0 | 1,500 | N/A |
| TOTAL | $0 | $0 | $0 | $20,210 | $20,210 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 3,650 | 3,653 |
| Other Non-Current Liabilities | 380 | 0 | 0 | 17,160 | 3,101 |
| TOTAL | $N/A | $N/A | $N/A | $27,150 | $6,754 |
| Total Liabilities | $0 | $0 | $0 | $47,370 | $47,377 |
| Shareholders' Equity | |||||
| Retained earnings | 0 | 0 | 0 | -45,150 | -45,151 |
| Other shareholders' equity | 0 | 0 | 0 | 9,380 | 9,378 |
| TOTAL | $0 | $0 | $0 | $-35,770 | $-35,773 |
| Total Liabilities And Equity | $0 | $0 | $0 | $11,600 | $11,604 |